Showing 1 - 12 results of 12 for search 'Tobias S. Slørdahl', query time: 0.04s
Refine Results
-
1
Teambasert læring – en studentaktiviserende og lærerstyrt undervisningsform by Børge Lillebo, Tobias S. Slørdahl, Ivar Skjåk Nordrum
Published 2017-01-01
Article -
2
Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango? by Anne Marit Sponaas, Anders Waage, Anders Waage, Esten N. Vandsemb, Kristine Misund, Magne Børset, Magne Børset, Anders Sundan, Tobias Schmidt Slørdahl, Tobias Schmidt Slørdahl, Therese Standal, Therese Standal
Published 2021-02-01
Article -
3
-
4
-
5
VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study by Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias S. Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold
Published 2024-04-01
Article -
6
P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY by Frida Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Diana Schjøll, Anna Lysén, Emil Hermansen, Fredrik Schjesvold
Published 2023-08-01
Article -
7
-
8
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration by Magnus Aassved Hjort, Håkon Hov, Pegah Abdollahi, Esten Nymoen Vandsemb, Unn-Merete Fagerli, Bendik Lund, Tobias Schmidt Slørdahl, Magne Børset, Torstein Baade Rø
Published 2018-04-01
Article -
9
P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OST... by Michael Gundesen, Fredrik Schjesvold, Annette Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Elena Todorescu, Bo Amdi Jensen, Tobias S. Slørdahl, Jon Thor Asmussen, Hareth Nahi, Anders Waage, Niels Abildgaard, Thomas Lund
Published 2023-08-01
Article -
10
Potential value of pre-planned imaging of bone disease in multiple myeloma by Michael T. Gundesen, Jon Thor Asmussen, Fredrik Schjesvold, Annette Juul Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias S. Slørdahl, Hareth Nahi, Anders Waage, Niels Abildgaard, Thomas Lund, Nordic Myeloma Study Group
Published 2023-07-01
Article -
11
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease by Thomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Jon Thor Asmussen, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias Schmidt Slørdahl, Hareth Nahi, Anders Waage, Niels Abildgaard, Fredrik Schjesvold, Nordic Myeloma Study Group
Published 2024-04-01
Article -
12
Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells by Kristin Roseth Aass, Robin Mjelle, Martin H. Kastnes, Synne S. Tryggestad, Luca M. van den Brink, Ingrid Aass Roseth, Marita Westhrin, Muhammad Zahoor, Siv H. Moen, Tonje M. Vikene Nedal, Glenn Buene, Kristine Misund, Anne-Marit Sponaas, Qianli Ma, Anders Sundan, Richard WJ. Groen, Tobias S. Slørdahl, Anders Waage, Therese Standal
Published 2022-01-01
Article